2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$15.86-$0.43 (-2.64%)
Price as of Jun 03, 2026 5:01 PM EDT- $563.9MMarket Cap
- 20.31%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$15.86-$0.43 (-2.64%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 100.0M +25.13% | 79.9M +22.14% | 65.4M +43.72% | 45.5M +0.75% | |
Cost of Revenue | 22.8M +9.34% | 20.8M +20.36% | 17.3M +32.79% | 13.0M +10.89% | |
Gross Profit | 77.2M +30.69% | 59.1M +22.78% | 48.1M +48.10% | 32.5M -2.82% | |
Sales and Marketing Expense | 46.6M -18.43% | 57.1M +4.74% | 54.5M +6.19% | 51.3M +31.78% | |
Research and Development Expense | -27.9M +17.90% | -23.7M +13.84% | -20.8M -5.32% | -21.9M +20.51% | |
Depreciation and Amortization Expense | 238,000 +14.98% | 207,000 +20.35% | 172,000 -35.58% | 267,000 -9.80% | |
Total Operating Expenses | 93.6M +15.85% | 80.8M +7.25% | 75.3M +2.74% | 73.3M +28.19% | |
Operating Profit | -16.3M -24.61% | -21.7M -20.25% | -27.2M -33.39% | -40.8M +71.86% | |
Interest Income | 2.8M -6.88% | 3.0M -0.85% | 3.0M +93.28% | 1.6M +252.23% | |
Interest Expense | -3.7M -57.95% | -8.8M +3.32% | -8.5M +13.12% | -7.5M +1.61% | |
Interest Income and Expense and Net | -884,000 -84.70% | -5.8M +5.65% | -5.5M -8.13% | -6.0M -14.52% | |
Total Nonoperating Income and Expense | -486,000 -259.87% | 304,000 +196.51% | -315,000 -6.53% | -337,000 -93.74% | |
Income before Taxes | -16.3M -24.61% | -21.7M -20.25% | -27.2M -33.39% | -40.8M +71.86% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -21.5M -20.91% | -27.1M -17.64% | -33.0M -30.00% | -47.1M +30.49% | |
Net Income from Continuing Operations Applicable to Common | -21.5M -20.91% | -27.1M -17.64% | -33.0M -30.00% | -47.1M +30.49% | |
Basic EPS and Net Income | -0.66 -29.03% | -0.93 -26.77% | -1.27 -33.51% | -1.91 -11.98% | |
Diluted EPS and Net Income | -0.66 -29.03% | -0.93 -26.77% | -1.27 -33.51% | -1.91 -11.98% | |
Basic Weighted Average Shares | 32.7M +12.35% | 29.1M +12.67% | 25.9M +5.11% | 24.6M +48.08% | |
Diluted Weighted Average Shares | 32.7M +12.35% | 29.1M +12.67% | 25.9M +5.11% | 24.6M +48.08% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 21.7M +61.52% | 13.4M -25.63% | 18.1M +173.40% | 6.6M -65.58% | |
Short-Term Investments | 39.4M +0.10% | 39.3M -18.74% | 48.4M -31.65% | 70.8M -26.55% | |
Cash and Cash Equivalents and Short-Term Investments | 61.1M +15.74% | 52.8M -20.61% | 66.5M -14.15% | 77.4M -33.03% | |
Total Current Assets | 94.1M +15.66% | 81.3M -12.27% | 92.7M -5.11% | 97.7M -26.43% | |
Accumulated Depreciation | 8.2M +2.91% | 8.0M +2.67% | 7.8M -10.97% | 8.7M +3.16% | |
Property and Plant and Equipment and Net | 1.1M +6.94% | 1.1M +4.89% | 1.0M -5.73% | 1.1M +76.45% | |
Total Long-Term Assets | 113,000 +653.33% | 15,000 0.00% | 15,000 -28.57% | 21,000 0.00% | |
Total Assets | 105.6M +11.54% | 94.6M -12.08% | 107.7M -5.66% | 114.1M -14.57% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 17.8M +17.54% | 15.2M -6.61% | 16.2M +47.86% | 11.0M +18.01% | |
Total Long-Term Debt | 58.9M -1.08% | 59.5M +4.51% | 57.0M +7.64% | 52.9M +6.15% | |
Total Long-Term Liabilities | 68.7M -3.86% | 71.5M +1.00% | 70.8M +3.53% | 68.4M N/A | |
Total Liabilities | 86.5M -0.12% | 86.6M -0.42% | 87.0M +9.67% | 79.3M +32.09% | |
Retained Earnings | -552.4M +4.04% | -531.0M +5.39% | -503.8M +7.00% | -470.9M +11.11% | |
Total Stockholders Equity | 19.0M +137.50% | 8.0M -61.20% | 20.7M -40.61% | 34.8M -52.69% | |
Total Shares Outstanding | 33.6M +11.38% | 30.1M +8.34% | 27.8M +11.09% | 25.0M +2.42% | |
Cash Flow | |||||
Cash from Operating Activities | -11.0M -38.68% | -17.9M -8.89% | -19.7M -46.56% | -36.9M +50.01% | |
Capital Expenditures | 332,000 +8.50% | 306,000 +76.88% | 173,000 -71.31% | 603,000 +57.03% | |
Cash from Investing Activities | -332,000 -103.69% | 9.0M -60.94% | 23.0M -3.24% | 23.8M +127.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 19.6M +352.97% | 4.3M -46.76% | 8.1M +1,558.57% | 490,000 -99.52% | |
Financials Ratio | |||||
Gross Margin | 77.23% +4.45% | 73.94% +0.52% | 73.56% +3.05% | 71.38% N/A | |
Operating Margin | -16.34% -39.75% | -27.12% -34.71% | -41.54% -53.65% | -89.62% N/A | |
Return on Assets | -21.44% -20.09% | -26.83% -9.72% | -29.72% -21.82% | -38.02% N/A | |
Return on Equity | -158.74% -16.17% | -189.35% +59.24% | -118.91% +36.73% | -86.96% N/A | |
Revenue Growth | 25.13% +13.50% | 22.14% -49.36% | 43.72% +5,761.27% | 0.75% N/A | |
Current Ratio | 5.28 -1.60% | 5.37 -6.06% | 5.71 -35.82% | 8.90 N/A | |
Cash Ratio | 1.22 +37.42% | 0.89 -20.36% | 1.11 +84.90% | 0.60 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow